Loomis, Sayles & Company’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,491
Closed -$25K 768
2019
Q1
$25K Buy
1,491
+362
+32% +$6.28K ﹤0.01% 611
2018
Q4
$17K Sell
1,129
-505
-31% -$8.66K ﹤0.01% 737
2018
Q3
$33K Sell
1,634
-342
-17% -$7.25K ﹤0.01% 660
2018
Q2
$39K Sell
1,976
-758
-28% -$12K ﹤0.01% 638
2018
Q1
$37K Buy
2,734
+344
+14% +$4.53K ﹤0.01% 639
2017
Q4
$32K Buy
2,390
+336
+16% +$4.83K ﹤0.01% 691
2017
Q3
$32K Buy
2,054
+45
+2% +$726 ﹤0.01% 683
2017
Q2
$35K Buy
2,009
+244
+14% +$3.71K ﹤0.01% 654
2017
Q1
$27K Buy
1,765
+49
+3% +$722 ﹤0.01% 724
2016
Q4
$23K Buy
1,716
+1,472
+603% +$18.9K ﹤0.01% 759
2016
Q3
$3K Buy
+244
New +$2.93K ﹤0.01% 946
2016
Q1
Sell
-167
Closed -$3K 1155
2015
Q4
$3K Hold
167
﹤0.01% 973
2015
Q3
$2K Sell
167
-148
-47% -$2.03K ﹤0.01% 994
2015
Q2
$5K Buy
+315
New +$5.08K ﹤0.01% 866

Other funds holding NXGN

Loomis, Sayles & Company's NXGN Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q2 2019, closing a stake of 1,491 shares — an estimated $25K sold.

Loomis, Sayles & Company first reported a position in NXGN in Q2 2015 and held it in 14 quarters. The position peaked at $39K in Q2 2018. 174 funds tracked by Wall St. Rank hold NXGN as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 1,491 NextGen Healthcare, Inc. Common Stock shares in Q2 2019, an estimated $25K.
  • Loomis, Sayles & Company first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2015 and held it in 14 quarters.
  • Loomis, Sayles & Company's NextGen Healthcare, Inc. Common Stock position peaked at $39K in Q2 2018.
  • 174 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.